Horiba Medical is proud to announce the development of its offer with the extension of the Hematology portfolio into the Hemostasis field. For over 30 years, Horiba Medical has developed its recognized proficiency in blood cell analysis. This scientific knowledge, innovation, leadership and cutting edge technology has been utilized to propose a new and comprehensive range of systems and reagents…
Since autumn 2016 a small tube has been making daily life easier for users and patients. A simple but effective addition now offers many new advantages in analysis, the manufacturer reports.
Teco Medical Instruments has produced coagulation analysers for a quarter of a century.
While IA’s (Immunoassay) has been the most used technic for clinical analysis, the shift to LC-MS / MS is constantly increasing for several type of analysis like immunosuppressant, vitamin D or steroids panel, but also for several new assays including anti-coagulants, antibiotics, plasma renin activity, etc. The change from Immunoassay to LC-MS / MS could have been faster if sample…
Tosoh and DiaSys announce a collaboration for clinical laboratory testing with the combination of Tosoh’s new generation analyzers (AIA-CL1200 for immunoassay and G11 for HbA1c) and DiaSys’ BioMajesty JCA-BM6010 / C. Instruments are linked through Evoline and Evoline Manager, Tosoh’s open laboratory automation and middleware solution. The collaboration addresses current requirements…
The Technion breathalyzer would give pathology groups and medical laboratories unprecedented ability to support physicians in diagnosing and treating cancers, chronic diseases, and other illnesses.
EKF Diagnostics are previewing the new connectivity solution for their range of point-of-care HbA1c analyzers at Arab Health 2017 on stand number Z1.H30.
The RX altona shines a new light on semi-automated clinical chemistry testing with increased auto-functionality and ground-breaking technology. Revolutionising the RX series with its bold look, innovative design, and outstanding performance, it sets the benchmark for the next generation of the RX series clinical chemistry analysers.
Patient care is the primary focus of clinical chemistry testing and Randox has developed the RX series of clinical chemistry analysers for high quality semi-automated and fully automated testing.
Identifying a blood disorder may be as easy as running a blood sample from a finger prick under a smartphone. That is the concept behind a new biomedical device being developed by Kansas State University researchers.
EKF Diagnostics, the global in vitro diagnostics company, announces that two research posters supporting the application of its PointMan DNA enrichment technology, for rapid and sensitive detection of lung cancer mutations, have been delivered at key conferences.
Wallace Coulter, one of the founders of Beckman Coulter, was motivated by a belief that science should serve humanity. This was the inspiration behind the principle he invented that became the basis for all blood counting solutions. This same drive to keep the science of hematology moving forward is behind Beckman Coulter's new ©Automated Intelligent Morphology© (AIM), a multidimensional,…
Clinical trials are under way at two NHS hospitals in England to assess breathalyser technology to detect lung cancer. Phase I clinical trials of a diagnostic breathalyser developed by Cambridge-based Owlstone Ltd have shown accurate identification of 12 lung cancer biomarkers in breath specimens. A Phase II trial is now targeting development of a small, handheld device that can be used in GP…
Patience and persistence are beginning to pay off for University of Montana Professor Mark Grimes, whose research about the behavior of cell proteins in childhood cancer recently was published by the Public Library of Science Computational Biology.
The Genspeed C. diff OneStep test, a CE-IVD certified molecular diagnostic test to detect nosocomial infections, has been added to the Greiner Bio-One portfolio.
Curetis AG, a developer of next-level molecular diagnostic solutions, announced the successful completion of the clinical and analytical CE performance evaluation of its next-generation Unyvero P55 Pneumonia Application. The upgraded cartridge will launch at the 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID, April 25 – 28, 2015 in Copenhagen, Denmark) and is…
Royal Philips today announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V. (Janssen). The collaboration aims to develop a new handheld blood test to provide doctors with a novel tool to improve the care of patients with neuropsychiatric disorders.
Dr Ahmed Abd El Wahed, research associate in the Department of Infection Models at the German Primate Centre (DPZ) in Göttingen, has developed a portable laboratory for fast diagnosis of Ebola. The new procedure is six to ten times faster than the one currently used, and equally sensitive. Report: Anja Behringer
Sphere Medical, launches its in-line patient dedicated arterial blood gas analyser in Germany, Netherlands and Belgium at ISICEM 2015. The advanced Proxima System delivers true point-of-care testing (POCT) by enabling critical care staff to obtain frequent laboratory accurate blood gas measurements without leaving the patient’s bedside. This facilitates effective and timely clinical decisions…
Iron deficiency and resulting anaemia cause fatal comorbidities worldwide. Despite this, they are generally underestimated. Professor Lothar Thomas, specialist in laboratory medicine at the Central Laboratory in the Frankfurt/Main University Hospital, is seeking more information about new laboratory parameters for diagnosis and monitoring of iron deficiency and iron substitution therapy. The…
A new CE-IVD certified molecular test has been added to Greiner Bio-One’s Genspeed test portfolio for nosocomial infections. In addition to the recently introduced MRSA test, the Genspeed C.diff OneStep test addresses the international need to combat Clostridium difficile (C. diff) infections. The test is analysed on the Genspeed R2 Analyser.
The University Medical Center in Utrecht (UMCU), The Netherlands, is in the process of creating a multidisciplinary centre of excellence, able to manage resources efficiently while delivering the highest level of patient care and clinical research.
Analysis from Frost & Sullivan suggests that the Western European next-generation sequencing (NGS) market is poised for steady growth with the emergence of new applications, such as non-invasive prenatal testing and comprehensive oncology panels.
For several decades pathologists worldwide have been under increasing pressure to handle a steady increase in laboratory tests with a steady decrease in finance and staff.
